DeepMed Research

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Optimizing Cerebral Autoregulation During Surgery

Not Applicable

Recruiting

Conditions: Surgery
Delirium
Hip Fractures
Hip Arthropathy

Interventions: Other: Blood pressure management according to cerebral autoregulation
Other: Blood pressure management according to usual care

First Posted Date: 2022-04-04

Last Posted Date: 2024-03-15

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 77

Registration Number: NCT05308290

Locations: 🇺🇸
The Johns Hopkins University, Baltimore, Maryland, United States

Effects of Psilocybin in Post-Treatment Lyme Disease

Phase 1

Completed

Conditions: Post-Treatment Lyme Disease
Lyme Disease, Chronic
Chronic Lyme Disease

Interventions: Drug: Psilocybin

First Posted Date: 2022-03-31

Last Posted Date: 2025-04-13

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 20

Registration Number: NCT05305105

Locations: 🇺🇸
Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States

Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought

Phase 1

Recruiting

Conditions: Healthy

Interventions: Drug: Psilocybin
Drug: Placebo

First Posted Date: 2022-03-29

Last Posted Date: 2024-12-19

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT05301608

Locations: 🇺🇸
Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore, Maryland, United States

OMEGA - Dietary Intervention - COPD Trial

Not Applicable

Recruiting

Conditions: COPD, Chronic Obstructive Pulmonary Disease

Interventions: Behavioral: Home delivery Omega-3 rich Food
Behavioral: Home delivery Food
Behavioral: Dietary Motivational Coaching

First Posted Date: 2022-03-28

Last Posted Date: 2025-03-20

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 200

Registration Number: NCT05297279

Locations: 🇺🇸
Johns Hopkins Bayview Campus, Baltimore, Maryland, United States

Effects of Recorded Music on Clinical and EEG Seizure Activity

Not Applicable

Recruiting

Conditions: Epilepsy

Interventions: Behavioral: Music Stimuli

First Posted Date: 2022-03-22

Last Posted Date: 2025-04-09

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 10

Registration Number: NCT05289934

Locations: 🇺🇸
Johns Hopkins School of Medicine, Baltimore, Maryland, United States

Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC

Phase 1

Completed

Conditions: Behavioral Pharmacology of Cannabis

Interventions: Drug: Oral Delta-8-THC Cannabis
Drug: Vaporized Delta-8-THC Cannabis
Drug: Oral Placebo
Drug: Vaporized Delta-9-THC Cannabis
Drug: Oral Delta-9-THC Cannabis
Drug: Vaporized Placebo

First Posted Date: 2022-03-18

Last Posted Date: 2024-10-08

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 28

Registration Number: NCT05287256

Locations: 🇺🇸
Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States

Clinic-based Versus Hotspot-focused Active TB Case Finding

Not Applicable

Recruiting

Conditions: Tuberculosis, Pulmonary
Mycobacterium Tuberculosis Infection

Interventions: Other: Active TB case finding with linkage to preventive therapy (ACF/TPT)

First Posted Date: 2022-03-17

Last Posted Date: 2025-03-04

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 150000

Registration Number: NCT05285202

Locations: 🇺🇬
Walimu, Kampala, Uganda

Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

Phase 2

Recruiting

Conditions: AMCI - Amnestic Mild Cognitive Impairment
Sleep Disturbance

Interventions: Drug: Trazodone
Drug: Placebo

First Posted Date: 2022-03-16

Last Posted Date: 2024-01-12

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 100

Registration Number: NCT05282550

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Trial to Determine Effective Aspirin Dose in COPD

Phase 3

Recruiting

Conditions: Pulmonary Disease, Chronic Obstructive

Interventions: Drug: Aspirin 81mg
Drug: Aspirin 162 mg
Drug: Aspirin 325mg

First Posted Date: 2022-03-03

Last Posted Date: 2025-03-14

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 48

Registration Number: NCT05265299

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care

Not Applicable

Completed

Conditions: Prediabetic State
PreDiabetes

Interventions: Other: START diabetes prevention clinical pathway

First Posted Date: 2022-03-03

Last Posted Date: 2025-02-05

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 1910

Registration Number: NCT05265312

Locations: 🇺🇸
Johns Hopkins General Internal Medicine clinic at Green Spring Station, Lutherville, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy